NeurAxis, Inc.
AMEX:NRXSBiotechnology
+$0.29 today
- Market cap
- $69.12M
- Beta
- 1.41
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.67
Volume 0.23M
Average 0.18M
NRXS Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
NeurAxis, Inc.AMEX: NRXS
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 253.0% from a year ago
Cash & equivalents stood at $7.08M at the end of Q1 FY2026, up 253.0% from a year earlier and up 42.6% from the prior quarter. Over 3 fiscal years it compounded at +169.5% a year.
Context
- Cash & equivalents amounted to 80.9% of total assets at the end of Q1 FY2026, up 14.8 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +253.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 4.97M USD
- Year-over-year change
- +34.3%
- 4-year CAGR
- +98.3%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.97M | +34.3% |
| FY2024 | 2024-12-31 | 3.7M | +4605.8% |
| FY2023 | 2023-12-31 | 78.56K | -69.0% |
| FY2022 | 2022-12-31 | 253.7K | -20.9% |
| FY2021 | 2021-12-31 | 320.86K | — |
Cash & Equivalents vs competitors
How NRXS compares with its peers on the latest reported figures
- NRXS's Mar 2026 cash & equivalents of $7.08M is the 3rd highest of the 4 companies compared; the peer median is $41.3M.
- Its year-over-year change of +253.0% is the 2nd highest of 4, against a peer median of +179.4%.
- Cash & equivalents amounts to 80.9% of total assets for NRXS, versus a peer median of 25.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $24.65B | +161575.2% | +31.6% | 25.9% | |
| Mar 2026 | $41.3M | +179.4% | -18.0% | 75.8% | |
NRXSNeurAxis, Inc. | Mar 2026 | $7.08M | +253.0% | +169.5% | 80.9% |
| Dec 2025 | $2.01M | -39.2% | -65.7% | 0.1% | |
| Peer median (excluding NRXS) | $41.3M | +179.4% | -18.0% | 25.9% | |
Competitors are the stored peer set for NRXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 320.86K | 253.7K | 78.56K | 3.7M | 4.97M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 115.3K | 174.4K | 73.17K | 244.62K | 195.7K |
| Inventory | 39.18K | 48.13K | 21.22K | 44.33K | 257.13K |
| Other Current Assets | 0 | 726 | 69.66K | 280.37K | 70.59K |
| Total Current Assets | 491.01K | 476.96K | 242.61K | 4.27M | 5.73M |
| Property, Plant & Equipment (Net) | 245.52K | 189.39K | 158.82K | 374.64K | 337.13K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 23.96K | 77.56K | 108.07K | 96.59K | 274.78K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 736.74K | 0 | 20.16K | 58.94K |
| Total Non-current Assets | 269.47K | 1M | 266.89K | 491.39K | 670.85K |
| Total Assets | 760.48K | 1.48M | 509.5K | 4.76M | 6.4M |
| Account Payables | 483.79K | 1.59M | 1.2M | 596.95K | 139.37K |
| Short-term Debt | 250.41K | 489.23K | 148.06K | 154.15K | 148.29K |
| Tax Payables | 563 | 777 | 0 | 0 | 0 |
| Deferred Revenue | 69.34K | 59.17K | 74.95K | 32.53K | 28.66K |
| Other Current Liabilities | 43.84K | 4.51M | 341.7K | 1.27M | 2.07M |
| Total Current Liabilities | 1.42M | 6.98M | 1.89M | 2.43M | 2.79M |
| Long-term Debt | 51.69K | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 10K |
| Total Non-current Liabilities | 161.29K | 76.2K | 27.07K | 256.5K | 212.57K |
| Total Liabilities | 1.59M | 7.05M | 1.91M | 2.69M | 3M |
| Common Stock | 2.55K | 1.96K | 6.51K | 6.99K | 10.65K |
| Retained Earnings | (29.15M) | (33.93M) | (48.56M) | (56.8M) | (64.6M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (825.66K) | (5.57M) | (1.4M) | 2.07M | 3.4M |
| Total Debt | 439.28K | 598.82K | 224.26K | 473.41K | 416.61K |
| Net Debt | 118.42K | 345.12K | 145.7K | (3.22M) | (4.55M) |
NeurAxis, Inc.
AMEX:NRXS
Intrinsic Alpha fair value
Locked
Current Price
$4.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.